CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
CANADA
  • US
    • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • News

Recommended picks

Significance of Early Preclinical Strategies for Biopharma Companies

Significance of Early Preclinical...

Microbiology and Its Value in Medicine

Microbiology and Its Value in Medicine

Clinical Trials' Burgeoning Concentration on Asia-Pacific Region

Clinical Trials' Burgeoning...

Reinforcing Clinical Trials with AI based Data Approach

Reinforcing Clinical Trials with AI...

Trends Driving APAC's Biopharmaceutical Industry

Trends Driving APAC's...

Different Fields of Agriculture Implementing Biotechnology

Different Fields of Agriculture...

The Value of New Antibiotics in the Fight Against AMR

The Value of New Antibiotics in the...

Improving Minimal Residual Disease Detection Using NGS

Improving Minimal Residual Disease...

Significance of Early Preclinical Strategies for Biopharma Companies

Significance of Early Preclinical...

Microbiology and Its Value in Medicine

Microbiology and Its Value in Medicine

Clinical Trials' Burgeoning Concentration on Asia-Pacific Region

Clinical Trials' Burgeoning...

Reinforcing Clinical Trials with AI based Data Approach

Reinforcing Clinical Trials with AI...

Trends Driving APAC's Biopharmaceutical Industry

Trends Driving APAC's...

Different Fields of Agriculture Implementing Biotechnology

Different Fields of Agriculture...

The Value of New Antibiotics in the Fight Against AMR

The Value of New Antibiotics in the...

Improving Minimal Residual Disease Detection Using NGS

Improving Minimal Residual Disease...

Best Practices to Improve Clinical Trial Recruitment

Life Sciences Review | Thursday, April 21, 2022
Tweet

Clinical trial sites increasingly rely on digital media for patient recruitment, yet many fail to achieve the desired results.


FREMONT, CA: While the COVID-19 epidemic has temporarily halted many clinical trials worldwide, clinicians, pharma companies, and research groups are still exploring potentially lifesaving drugs and clinical approaches. Patients participating in clinical trials should access them easily, feel protected and be a part of the process.


Before starting this process, many elements must be considered, from pre-trial recruitment to initial engagement and onboarding to communication consistency and transparency. The pharma companies may prevent challenges with regulatory compliance, patient accessibility, high drop-out rates, and other variables that typically stall the development of these studies by better knowing what patients need and want from a clinical trial experience.


The virtue of patients: The patient's situation is likely the essential thing to consider while recruiting for clinical trials. Pharma companies must grasp what patients want to know before joining in a clinical study. Patient feedback indicates that knowing the trial's risks and benefits helps them make decisions. In addition, many patients struggle to follow medical recommendations due to a lack of health literacy. Pharma businesses must use straightforward language and evaluate their resources' reading level before using them in advertising. For marketing, enrollment, and retention, pharma companies must understand patients' opinions.


Completely recognize the advertising venues: The pharma companies must understand each platform’s advertising and message policies to recruit patients. While platforms such as Google and Facebook are frequently used to recruit trial participants, they also have stringent guidelines for this type of participation. Recruiters often encounter delays in ad clearance due to initial messaging that does not adhere to the platform's requirements. The pharma firms can avoid these delays by conducting thorough research on advertising policies and starting from there. Additionally to this best practice, they should have a well-defined process for analyzing trial results and correctly reporting outcomes.


Consider the Cornerstones of Clinical Trials: Compliance with informed consent processes, inclusion and exclusion criteria, proper and timely safety monitoring, adherence to protocol-mandated investigations and follow-up, and evaluation of regulatory documentation are all critical factors to monitor in all trials. There is substantial evidence that trial participants desire transparency, collaboration, and consistent engagement. One recent study demonstrates that patients wish to be informed about overall trial outcomes and the widespread use of their drugs following their investigation. The pharma companies must keep the following fundamental principles in mind when attempting to retain trial participants:



  • Engagement

  • Consent Comprehension

  • Adherence Monitoring

  • See Also: Top Core Banking Technology Solution Companies


Weekly Brief

loading
Top 10 Clinical-Stage Biopharmaceutical Companies in APAC - 2022
> <
  • Regulatory Services 2023

    Top Vendors

    Current Issue
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue
  • Regulatory Services 2023

    Top Vendors

    Current Issue
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue

Read Also

The Role of AI in Accurate Medical Writing

Patrik Renblad to Join Cantargia as Chief Financial Officer

Overview of the Life Sciences BPO Market

Dr. Zamaneh Mikhak Joins TFF Pharmaceutical as the New Chief Medical Officer

The Significance of AI in Medical Writing

The Importance of Technology in Multinational Clinical Research

Hepion Pharmaceuticals to Get a Total of $ 3.2 Million in Non-Dilutive Financing

Benefits that Medical Writing Offers

Loading...

Copyright © 2023 Life Sciences Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/news/best-practices-to-improve-clinical-trial-recruitment-nwid-480.html